dPCR and qPCR Products Market to Grow with a CAGR of 7.20% through 2029
Continuous advancements in PCR technologies and
growing importance of PCR in biomarker discovery is expected to drive the
Global dPCR and qPCR Products Market growth in the forecast period, 2025-2029.
According to TechSci Research report, “dPCR and
qPCR Products Market – Global Industry Size, Share, Trends, Competition
Forecast & Opportunities, 2029F”, the Global dPCR and qPCR Products
Market stood at USD 8.12 billion in 2023 and is anticipated to grow with a CAGR
of 7.20% through 2029. The dPCR and qPCR industry is projected to
witness substantial growth in the near future. This is attributed to the
growing demand for precise, accurate, and efficient detection of nucleic acids
across various applications, including gene expression analysis, disease
diagnosis, and food safety testing.
The growth of the market is anticipated to be primarily fueled by advancements in highly sensitive and specific instruments, reagents, and assays for digital PCR (dPCR) and quantitative PCR (qPCR). Furthermore, the introduction of next-generation sequencing (NGS) methods, including single-cell sequencing, is poised to drive further expansion in the dPCR and qPCR industry. The increasing demand for personalized medicine and rapid diagnostics is expected to unlock numerous opportunities within the dPCR and qPCR sector.
Factors such as the rising incidence and prevalence of target infectious diseases and genetic disorders, continuous technological advancements in PCR technologies, growing significance of PCR in biomarker discovery, and increasing investments and funding are contributing to the growth of the market. The escalating prevalence of genetic disorders and major infectious diseases, coupled with the growing utilization of biomarker profiling for disease diagnostics, are significant drivers fueling the demand for technologically advanced PCR tests in the foreseeable future.
In the coming years, significant technological advancements, augmented investments, funding, and grants are expected to further drive the demand for digital PCR across various applications. The transition from plant-based to genome-based drug discovery is also expected to present opportunities for market growth. However, technical limitations associated with PCR and the increased cost of PCR devices may hinder market growth. Nevertheless, the development of portable, compact, and lab-on-chip PCR devices, along with technological integration, is expected to drive market expansion. Increased investments and access to funding and grants are supporting the surge in research and development activities, with governments and federal organizations worldwide increasingly recognizing the significance of qPCR and dPCR technologies in genomics research. Numerous financing initiatives have been undertaken to support genomic research in the qPCR and dPCR industries over the past decade.
Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global dPCR and qPCR Products Market”
The Global dPCR
and qPCR Products Market is segmented into product, application, end user,
regional distribution, and company.
Based on By Priduct, The dPCR and qPCR Products Market is segmented into reagents & consumables, instruments, and software. It is anticipated that the reagents and consumables segment will dominate, holding the largest market share. This is attributed to the increasing adoption of dPCR and qPCR products by researchers and healthcare professionals. The trend is driven by the automation and miniaturization of qPCR/dPCR instruments, the availability of advanced software, and customized laboratory reagents. Moreover, the global uptake of MIQE guidelines is bolstering the use of qPCR/dPCR reagents among researchers. Additionally, the expanding applications of qPCR, offering technological advantages over traditional PCR, such as real-time analysis and reduced analysis time, are expected to further drive the growth of the reagents and consumables market.
Based on region, The North America segment is poised for growth throughout the forecast period. According to regional analysis, North America emerged as the leader in the dPCR and qPCR Products Market in 2023, with Europe following closely behind. The expansion of the North American dPCR and qPCR Products Market is driven by several factors, including the increasing adoption of innovative genomic analysis products, the availability of substantial research and development funding, a robust research infrastructure, the growing utilization of PCR techniques in clinical diagnostics and forensics, and the early commercialization of qPCR/dPCR products in the region. North America is anticipated to maintain its dominance in the overall market throughout the forecast period, propelled by various factors such as the presence of key industry players, a high prevalence of chronic diseases, and a well-established healthcare infrastructure. Moreover, beneficial government initiatives and a rise in research partnerships are expected to further stimulate market growth. Among the countries in this region, the United States holds the largest share due to its supportive healthcare policies, a substantial patient population, and a mature healthcare market.
Major companies
operating in Global dPCR and qPCR Products Market are:
- Abbott Laboratories, Inc.
- Agilent Technologies, Inc.
- Analytik Jena AG
- Becton Dickinson and Company
- Bio Molecular Systems Pty Ltd
- Biomeme Inc.
- Biomérieux S.A.
- Bioneer Corporation
- Bio-Rad Laboratories, Inc.
- Cole-Parmer Instrument Company llc
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“Factors such as
the growth in the geriatric population, rising incidence of infectious diseases
and genetic disorders, technological advancements in the field of PCR, and
increasing investments and availability of funds for PCR-based research are
driving the growth of the global dPCR and qPCR Products Market. Moreover, the market is
being propelled by the increasing advancements in PCR techniques and research
activities that utilize PCR. The expansion of healthcare infrastructure, an
increase in healthcare expenditure, and lower procedural costs for qPCR and
dPCR-based illness diagnostics are significant drivers for these markets. The
growing healthcare infrastructure in emerging countries is accompanied by the
rapid upgrading of healthcare facilities, which leads to higher demand for
clinical diagnostic procedures in diagnostic laboratories. This, in turn, results
in increased sales of clinical qPCR and dPCR products. Additionally, increased
public-private investments to raise awareness about illness diagnostics and the
introduction of technologically sophisticated products are contributing to the
forward momentum of the Global dPCR and qPCR Products Market”, said Mr.
Karan Chechi, Research Director of TechSci Research, a research-based
management consulting firm.
“dPCR and qPCR Products Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Reagents & Consumables, Instruments, And Software), By Application (Clinical Applications, And Forensic Applications), By End User (Hospitals & Diagnostic Centres, Research Laboratories & Academic Institutes, Clinical Research Organizations, And Others), By Region and Competition, 2019-2029F", has evaluated
the future growth potential of Global dPCR and qPCR Products Market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global dPCR and qPCR Products Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com